Showing results (11-20 of 161) with videos related to
Sort By:
Pageof 17
Cell Transplantation|May 25, 2006
CNS gene therapy and a nexus of complexity: systems and biology at a crossroadsCarolyn M Tyler, Howard J FederoffFrontiers in Aging Neuroscience|June 24, 2017
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's DiseaseSudhakar R Subramaniam, Howard J FederoffExperimental Neurology|March 26, 2013
Using viral-mediated gene delivery to model Parkinson's disease: do nonhuman primate investigations expand our understanding?Massimo S Fiandaca, Howard J FederoffScience Translational Medicine|September 30, 2011
Disclosure of clinical trial results when product development is abandonedMichael A Rogawski, Howard J FederoffAlzheimer Disease and Associated Disorders|September 27, 2003
Current treatment for Alzheimer disease and future prospectsPierre N Tariot, Howard J FederoffNeurorx : the Journal of the American Society for Experimental Neurotherapeutics|July 4, 2006
Microarrays in Parkinson's disease: a systematic approachRenee M Miller, Howard J FederoffScience of Aging Knowledge Environment : SAGE KE|November 19, 2005
Immune shaping and the development of Alzheimer's disease vaccinesHoward J Federoff, William J BowersCurrent Opinion in Molecular Therapeutics|November 13, 2004
Safety of viral vectors for neurological gene therapiesKathleen A Maguire-Zeiss, Howard J FederoffJournal of Neural Transmission (Vienna, Austria : 1996)|June 16, 2010
Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's diseaseKathleen A Maguire-Zeiss, Howard J FederoffAnnals of the New York Academy of Sciences|July 9, 2003
Convergent pathobiologic model of Parkinson's diseaseKathleen A Maguire-Zeiss, Howard J FederoffPageof 17